1190 related articles for article (PubMed ID: 19121776)
1. Lipid and lipoprotein metabolism in chronic kidney disease.
Kaysen GA
J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
[TBL] [Abstract][Full Text] [Related]
2. Disorders in high-density metabolism with insulin resistance and chronic kidney disease.
Kaysen GA
J Ren Nutr; 2007 Jan; 17(1):4-8. PubMed ID: 17198924
[TBL] [Abstract][Full Text] [Related]
3. New insights into lipid metabolism in chronic kidney disease.
Kaysen GA
J Ren Nutr; 2011 Jan; 21(1):120-3. PubMed ID: 21195934
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia in chronic kidney disease.
Kaysen GA
Int J Artif Organs; 2007 Nov; 30(11):987-92. PubMed ID: 18067100
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral contraceptives on lipid metabolism.
Krauss RM
J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
[TBL] [Abstract][Full Text] [Related]
7. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
Braschi S
Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and renal failure: similarities and differences.
Kaysen GA
Panminerva Med; 2006 Sep; 48(3):151-64. PubMed ID: 17122751
[TBL] [Abstract][Full Text] [Related]
9. Abnormal fat metabolism in chronic renal failure.
Romics L; Makó J
Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
Vaziri ND
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F262-72. PubMed ID: 16403839
[TBL] [Abstract][Full Text] [Related]
11. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
Wiemer J; Scherberich JE
MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
13. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
Vaziri ND
J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome.
Rocha MP; Maranhão RC; Seydell TM; Barcellos CR; Baracat EC; Hayashida SA; Bydlowski SP; Marcondes JA
Fertil Steril; 2010 Apr; 93(6):1948-56. PubMed ID: 19765700
[TBL] [Abstract][Full Text] [Related]
15. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
16. [High-density-lipoprotein and renal insufficiency (author's transl)].
Graf H; Stummvoll HK; Müller MM
Wien Klin Wochenschr; 1982 Jan; 94(2):39-41. PubMed ID: 7080495
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in factors that alter lipid metabolism in chronic renal failure.
Drüeke T; Lacour B; Roullet JB; Funck-Brentano JL
Kidney Int Suppl; 1983 Dec; 16():S134-8. PubMed ID: 6588243
[TBL] [Abstract][Full Text] [Related]
18. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
19. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.
Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR
Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics.
Gylling H; Färkkilä M; Vuoristo M; Miettinen TA
Hepatology; 1995 Jan; 21(1):89-95. PubMed ID: 7806174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
